Fewer Deaths Expected with New Version of Endoscope
Micah Strong, CEO of Endosight, announced his company’s new breakthrough in endoscopic medical technology today in a press conference. Using machine learning and industrial robotics, Strong’s company has a new device for endoscopic procedures used by internal medicine doctors and gastroenterologists to explore and diagnose medical conditions in the lower intestine. The Lower GI Pro Endoscope Mark III is a clear turning point in patient comfort and efficiency in the exploratory and diagnostic process. The previous Mark II endoscope was plagued with problems and subsequent lawsuits from doctors and patients that were injured or killed using that product. Strong indicated that the problems with the Mark II have been corrected and that he expects many fewer deaths and injury using the Mark III. He pointed to the new ChatGPT interface, image recognition machine learning system, and larger industrial robot arm with the Mark III product. Medical product safety advocates warn that Endosight continues to build unsafe products that will likely kill or injury hundreds to thousands of patients each year. The FDA has already approved the new product for use. Mr. Strong also hinted at new medical products coming soon to replace the doctor and associated staff, allowing large hospital systems to eliminate expensive and pesky humans with complex automated systems providing more cost-efficient, faster, and less empathetic healthcare services. Human trials should are scheduled to start soon.